Page 173 - Read Online

amino acidconcentrated in neurons that functions Conflicts of interest
as a neuronal marker. Any destruction of neurons, There are no conflicts of interest.
such as noted by high grade malignant tumors or
radiation-induced necrosis, decreases the amount of REFERENCES
NAA and thus reduces its peak in MR spectroscopy.
Choline (Cho) is an essential nutrient that, in 1. Assimakopoulos A, Polyzoidis K, Kyritsis AP. Stem Cells in
Gliomas. J Stem Cells Res, Rev Rep 2014;1:1009.
addition to being a precursor in acetylcholine 2. Kyritsis AP, Levin VA. An algorithm for chemotherapy treatment
synthesis, is a basic component of sphingomyelin of recurrent glioma patients after temozolomide failure in
and phosphatidylcholine, both constituents of cell the general oncology setting. Cancer Chemother Pharmacol
2011;67:971-83.
membranes. During MR spectroscopy, Increased 3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B,
Cho indicates higher cellularity, as seen in tumors, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
and decreased Cho indicates radiation-induced U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier
A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO;
necrosis. In general, an increased ratio of Cho/NAA European Organisation for Research and Treatment of Cancer
is indicative of brain tumor growth. In our patients, a Brain Tumor and Radiotherapy Groups; National Cancer
Cho/NAA > 3.63 was considered a strong suggestion Institute of Canada Clinical Trials Group. Radiotherapy plus
concomitant and adjuvant temozolomide for glioblastoma. N
for tumor recurrence, rather than radiation necrosis. Engl J Med 2000;352:987-96.
Partial resection of the tumor mass and histologic 4. Nasseri M, Gahramanov S, Netto JP, Fu R, Muldoon LL,
examination demonstrated the presence of recurrent Varallyay C, Hamilton BE, Neuwelt EA. Evaluation of
pseudoprogression in patients with glioblastoma multiforme
tumor. However, in some areas of the mass, the using dynamic magnetic resonance imaging with ferumoxytol
occurrence of radiation-induced changes may at calls rano criteria into question. Neuro Oncol 2014;16:1146-54.
least partially explain the discrepancy between the 5. Soffietti R, Leoncini B, Ruda R. New developments in the
treatment of malignant gliomas. Expert Rev Neurother
various imaging modalities. 2007;7:1313-26.
6. Alexiou GA, Tsiouris S, Voulgaris S, Kyritsis AP, Fotopoulos AD.
In conclusion, the differentiation of treatment Glioblastoma multiforme imaging: the role of nuclear medicine.
induced necrosis from glioblastoma recurrence or 7. Curr Radiopharm 2012;5:308-13.
Assimakopoulos A, Polyzoidis KS, Sioka C. Positron
progression is imperative in order to employ the emission tomography imaging in gliomas. Neuroimmunol
appropriate treatment. Although it may be impossible Neuroinflammation 2014;1:107-14.
to differentiate such a condition with conventional 8. Alexiou GA, Zikou A, Tsiouris S, Goussia A, Kosta P,
Papadopoulos A, Voulgaris S, Tsekeris P, Kyritsis AP, Fotopoulos
imaging, new technology, such as combination of AD, Argyropoulou MI. Comparison of diffusion tensor, dynamic
diffusion/perfusion MRI, MR spectroscopy with susceptibility contrast mri and (99m)tc-tetrofosmin brain spect
either PET or SPECT, should be able to accurately for the detection of recurrent high-grade glioma. Magn Reson
Imaging 2014;32:854-9.
diagnose the patient’s condition. In rare cases, such 9. Alexiou GA, Tsiouris S, Goussia A, Papadopoulos A, Kyritsis AP,
as in ours, biopsy may be needed if the imaging Polyzoidis KS, Fotopoulos AD. Evaluation of glioma proliferation
methods are contradictory. by 99mTc-Tetrofosmin. Neuro Oncol 2008;10:104-5.
10. Zhang H, Ma L, Wang Q, Zheng X, Wu C, Xu BN. Role of
magnetic resonance spectroscopy for the differentiation of
Financial support and sponsorship recurrent glioma from radiation necrosis: a systematic review
Nil. and meta-analysis. Eur J Radiol 2014;83:2181-9.

164 Neuroimmunol Neuroinflammation | Volume 3 | July 8, 2016